Booking (NASDAQ:BKNG – Free Report) had its price objective increased by JMP Securities from $5,000.00 to $5,400.00 in a research note issued to investors on Friday morning, Benzinga reports. The firm currently has a market outperform rating on the business services provider’s stock.
A number of other equities analysts also recently commented on BKNG. DA Davidson boosted their target price on shares of Booking from $4,100.00 to $5,005.00 and gave the stock a “buy” rating in a report on Thursday, October 31st. JPMorgan Chase & Co. reduced their price objective on shares of Booking from $4,025.00 to $3,860.00 and set an “overweight” rating for the company in a research note on Friday, August 2nd. B. Riley raised their target price on shares of Booking from $4,650.00 to $5,100.00 and gave the company a “buy” rating in a research note on Thursday, October 31st. Bank of America raised their price objective on Booking from $4,448.00 to $4,850.00 and gave the stock a “neutral” rating in a research report on Thursday, October 31st. Finally, Wedbush upped their price target on shares of Booking from $3,900.00 to $4,750.00 and gave the company an “outperform” rating in a research note on Friday, October 25th. Twelve investment analysts have rated the stock with a hold rating, twenty-one have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $4,708.45.
Check Out Our Latest Research Report on Booking
Booking Stock Performance
Booking Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 31st. Stockholders of record on Friday, December 6th will be paid a $8.75 dividend. This represents a $35.00 annualized dividend and a dividend yield of 0.73%. The ex-dividend date is Friday, December 6th. Booking’s payout ratio is presently 23.75%.
Insider Transactions at Booking
In other Booking news, insider Paulo Pisano sold 100 shares of the firm’s stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $3,887.61, for a total transaction of $388,761.00. Following the transaction, the insider now owns 3,787 shares of the company’s stock, valued at approximately $14,722,379.07. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.12% of the company’s stock.
Institutional Investors Weigh In On Booking
Institutional investors have recently added to or reduced their stakes in the business. Jamison Private Wealth Management Inc. purchased a new stake in shares of Booking in the third quarter valued at about $25,000. Grove Bank & Trust increased its position in Booking by 133.3% during the 2nd quarter. Grove Bank & Trust now owns 7 shares of the business services provider’s stock worth $28,000 after purchasing an additional 4 shares in the last quarter. POM Investment Strategies LLC acquired a new position in Booking in the 2nd quarter valued at about $28,000. Kings Path Partners LLC purchased a new position in Booking in the 2nd quarter valued at about $28,000. Finally, West Financial Advisors LLC acquired a new stake in shares of Booking during the 3rd quarter worth about $29,000. Hedge funds and other institutional investors own 92.42% of the company’s stock.
About Booking
Booking Holdings Inc, formerly The Priceline Group Inc, is a provider of travel and restaurant online reservation and related services. The Company, through its online travel companies (OTCs), connects consumers wishing to make travel reservations with providers of travel services across the world. It offers consumers an array of accommodation reservations (including hotels, bed and breakfasts, hostels, apartments, vacation rentals and other properties) through its Booking.com, priceline.com and agoda.com brands.
Further Reading
- Five stocks we like better than Booking
- Health Care Stocks Explained: Why You Might Want to Invest
- Intel: Is Now the Time to Be Brave?Â
- Profitably Trade Stocks at 52-Week Highs
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- How to Plot Fibonacci Price Inflection Levels
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Booking Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Booking and related companies with MarketBeat.com's FREE daily email newsletter.